[1]
Бобро, Л.Н. and Паровіна, А.В. 2016. Aspects of safety of application of chondroprotectors for patients nonalcoholic fatty liver disease. Family medicine. 2(64) (May 2016), 110–112. DOI:https://doi.org/10.30841/2307-5112.2(64).2016.102419.